Development and exploration of an AI model to classify "healthy subject" and "suspected schizophrenia patient" based on free conversations with medical staff

JRCT ID: jRCT1030210514

Registered date:26/12/2021

Basic Information

• Recruitment status: Complete
• Health condition(s) or Problem(s) studied: Schizophrenia
• Date of first enrollment: 08/12/2021
• Target sample size: 150
• Study type: Observational

Outcome(s)

Primary Outcome

Development and exploration of an following AI model based on free conversations with medical staff
*to classify "healthy subject" and "suspected schizophrenia patient"
*to classify the history of hospitalization for schizophrenic patient

Key inclusion & exclusion criteria

• Age minimum: >= 18age old
• Age maximum: <= 65age old
• Gender: Both

Include criteria

1) Schizophrenia
Between 18 and 65 years of age at the time of consent and diagnosed with schizophrenia according to the DSM-5.

2) Healthy Subject
Between the ages of 18 and 65 years old at the time of consent.

1)2) in Common
*Who speak Japanese as his/her mother tongue and able to have an interview (conversation with doctors and medical staff)
*Who can obtain written consent from the person and also his / her substitute if the subject is under 20 years old.

Exclude criteria

*Who has been judged by a doctor to have difficulty in having conversation due to deafness, dysarthria, aphasia, etc.
*Who has been diagnosed of having a pyschiatric disorder such as depression
*Who has been diagnosed of a dementia or judged to have cognitive dysfunction due to neurological diseases (epilepsy, stroke, etc.)
*Who has been judged by a doctor not to be suitable for this trial by any reasons

Related Information

• Primary Sponsor: Yuichiro Tsutsumi
• Source(s) of Monetary Support: Sumitomo Dainippon Pharma Co., Ltd.